On July 30, the 24th Vietnam International Medical & Pharmaceutical Expo (Vietnam Medi-Pharm Expo 2026) opened at the Saigon Exhibition and Convention Center (SECC) in Ho Chi Minh City. Supported by Vietnam’s Ministry of Health, the event is one of Southeast Asia’s most influential professional medical exhibitions, bringing together more than 300 companies from 15 countries and regions to present advances in pharmaceuticals, medical devices, and broader healthcare solutions.
At this international showcase, Wuhan BBT Medical presented its latest minimally invasive surgical solutions, highlighting the strength of China’s minimally invasive technology to partners worldwide.
On-site focus: Chinese innovation draws attention in Southeast Asia
BBT Medical’s Booth C01 became a busy hub. The company highlighted core product lines including ultrasonic surgical systems and endoscopic stapler systems. Live demonstrations emphasized precision, reliability, and ergonomic design, attracting representatives from the Ho Chi Minh City Medical Equipment Association (HMEA), public hospital procurement teams, distributors, and clinical partners.
With years of experience in minimally invasive surgery, BBT’s portfolio spans gynecology, general surgery, breast and thyroid surgery, and more—evolving from standalone devices to integrated solutions. The exhibition also featured CE-certified manufacturing and full OEM/ODM customization from R&D through production, offering international partners end-to-end support.
Vietnam’s rapidly growing medical market creates major opportunities for Chinese medtech companies going global. Participation in Vietnam Medi-Pharm Expo is both a window to showcase Chinese innovation in Southeast Asia and an important step in BBT Medical’s international expansion, laying a solid foundation for deeper engagement in Vietnam and neighboring markets.
Technology leadership on display
Strong booth interest reflects BBT’s long-term investment in minimally invasive technology. The featured ultrasonic surgical system combines ultrasonic and RF dual-energy synergy, enabling secure closure of vessels up to 7 mm with simultaneous cutting and coagulation. It has obtained China’s Class III medical device registration and EU CE certification, meeting demanding benchmarks for temperature control, cutting speed, sealing strength, and thermal spread—supporting complex procedures in thoracic, hepatobiliary, gastrointestinal, and gynecologic surgery.
The electric endoscopic stapler system on display integrates eight core technologies, offering broad size coverage, precise cutting and sealing performance, and stable handling—delivering a high-quality, adaptable, and cost-effective domestic option for hospitals at different levels.
From China to the world, Wuhan BBT Medical continues advancing toward a leading position in global minimally invasive surgery under its mission of “Health is half the sky, benefiting all mankind.” The company will keep investing in core technology and delivering dependable “China solutions” for clinical needs worldwide.
